Netherlands· NL-2f4ae5bf6ea6
Okitask 25 mg omhuld granulaat
A ketoprofen product containing ketoprofen-(d,l)-lysine, registered in Netherlands by Dompe Farmaceutici S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ketoprofen is registered in 12 of 19 countries.
Countries holding a registration under ATC M01AE03 (ketoprofen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Ketoprofen · ATC M01AE03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ketoprofen costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ketoprofen · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- IT Italy$0.27
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- KETOPROFEN-(D,L)-LYSINE
- Manufacturer
- Dompe Farmaceutici S.p.A.
- Country
- Netherlands (NL)
- ATC code
- M01AE03
- ATC class
- Ketoprofen
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id118238
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
290 interactions on record for ketoprofen.
Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ketoprofen · interactions on record
290 records
- 58 severe
- 146 moderate
- 5 minor
- 81 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ketoprofen in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainOKIDOL 25 MG GRANULADODompe' Farmaceutici S.P.A.
- FinlandOkitaskDompé Farmaceutici S.p.A
- PolandOkitaskDompe Farmaceutici S.p.A.
- United KingdomFenoket 200mg modified-release capsulesOpus Pharmaceuticals Ltd
- CzechiaFASTUMA. Menarini Industrie Farmaceutiche Riunite S.r.l., Florencie
- ItalyALKETS.F. GROUP S.R.L.
- FranceBI PROFENID LP 100 mg, comprimé sécable à libération prolongéePHOENIX LABS (IRLANDE)
- BelgiumBirofenid 150 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Fastum, Ketospray
- Belgium · Fastum
- Bulgaria · Ketospray, Артрокол
- Cyprus · Fastum
- Czechia · Fastum, Keplat
- Germany · Alrheumun, Effekton
- Estonia · Fastum, Keto
- Spain · Fastum
- Finland · Keto, Ketorin
- France · Bi Profenid Lp, Ketoprofene Aguettant
- United Kingdom (Northern Ireland) · Ketoprofen, Ketoprofen Ennogen Ip
- Greece · Drastirel
- Croatia · Fastum, Ketonal
- Hungary · Fastum, Keplat
- Ireland · Fastum
- Italy · Alket, Dolgosin
- Lithuania · Fastum, Ketonal
- Luxembourg · Fastum, Ketoprofene Aguettant
- Latvia · Fastum, Keto
- Malta · Fastum, Ketokaps Max
- Poland · Fastum, Febrofen
- Portugal · Kepin, Keplat
- Romania · Fastum, Ketomag
- Sweden · Siduro
- Slovenia · Ketonal, Ketonal 100 Mg
- Slovakia · Fastum, Ketonal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f22ffe7e-770b-4544-8e91-4289dca9657e GET /v1/drugs/f22ffe7e-770b-4544-8e91-4289dca9657e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Omhuld granulaat",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118238_smpc.pdf",
"strength": null,
"atc_label": "Ketoprofen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118238",
"excipients": [
"ARABISCHE GOM (E 414)",
"BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
"BUTYLHYDROXYANISOL (E 320)",
"CITROENSMAAKSTOF",
"FRESCOFORTSMAAKSTOF",
"GLUCOSE 0-WATER",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"LIMOENSMAAKSTOF",
"MAGNESIUMSTEARAAT (E 470b)",
"MALTODEXTRINE",
"MALTODEXTRINE",
"MANNITOL (D-) (E 421)",
"MAÏSZETMEEL, GEMODIFICEERD",
"MAÏSZETMEEL, GEMODIFICEERD",
"NATRIUMLAURILSULFAAT",
"POVIDON K 25 (E 1201)",
"SACCHAROSE",
"SILICIUMDIOXIDE (E 551)",
"STEARINEZUUR (E 570)",
"TALK (E 553b)",
"XYLITOL (E 967)"
],
"substances": [
"KETOPROFEN-(D,L)-LYSINE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118238.pdf",
"authorised_at": "2017/07/10",
"procedure_number": "NL/H/3583/001",
"dispensing_status": "Uitsluitend apotheek$SEMICOLON$ Uitsluitend apotheek of drogist - UA meer dan 16 eenheden - UAD maximaal 16 eenheden",
"registration_number": "118238",
"additional_monitoring": "N"
}See everything about ketoprofen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.